Business
Sonde Gets $19M+ for Voice-Based Health Monitoring
Sonde Gets $19M+ for Voice-Based Health Monitoring.
About this update from Puretech Health Plc
[{"type":"text","content":"\n \n \n \n 9 December 2022\n \n \n \n PureTech Health plc\n \n \n \n \n \n \n \n PureTech Founded Entity\n Sonde Health Raises $19.25 Million Series B for Voice-Based Health Monitoring\n \n \n AI vocal biomarker company will use funding to accelerate its commercial growth, expand its platform into new health conditions, and enter new geographies\n \n \n PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (\"PureTech\" or the \"Company\"), a clinical-stage biotherapeutics company, noted today that its Founded Entity, Sonde Health, a health technology company committed to bringing accessible health monitoring to everyone, announced it has raised a $19.25 million Series B investment round with a strong group of financial and strategic investors.\n Sonde has the largest and most diverse health-labeled voice dataset with over 1.2 million voice samples from over 85,000 subjects on 4 continents. Sonde uses advanced audio signal processing, speech science and AI/machine learning to sense and analyze subtle vocal changes due to changes in a person's physiology to provide key insights into health and well-being.\n The Sonde platform has applications in a range of indications including asthma, COPD, depression, anxiety mild cognitive impairment, and general health.\n Sonde has raised $35.25 million in total.\n \n The full text of the announcement from Sonde is below:\n \n \n \n \n \n Sonde Health Raises $19.25 Million Series B to Build the Next Generation of Voice-Based Health Monitoring\n \n \n AI vocal biomarker company will use funding to accelerate its commercial growth, expand its platform into new health conditions, and enter new geographies\n \n \n BOSTON - Dec. 8, 2022 -\n \n Sonde Health\n , a health technology company committed to bringing accessible health monitoring to everyone, has raised a $19.25 million Series B investment round led by Partners Investment, with participation from NEOM Company, KT Corporation, and existing investors, including co-founder PureTech Health and M Ventures. The company has raised $35.25 million in total and will use the funding to drive its global commercial growth, deepen its respiratory and mental health monitoring technologies, and build capabilities for additional health conditions.\n \"Digital biomarkers are becoming a mainstay in healthcare. Today's healthcare companies are realizing ...